公司概述
Aflac Incorporated operates primarily as a provider of supplemental health and life insurance products, serving customers through a dual-segment structure that encompasses both Aflac Japan and Aflac U.S. entities. The company functions within the broader Financial Services sector, specifically categorized under the Insurance - Life industry, where it manages significant risk exposure and asset-liability management responsibilities. On a scale that reflects its established market presence, Aflac Incorporated boasts a market capitalization of $59.26B, generates annual revenue of $17.16B, and employs a workforce of 12,716 individuals. These valuation and revenue figures indicate that the company maintains a substantial position within the insurance landscape, supported by a large operational footprint that allows for diversified product offerings across distinct geographic markets.
财务健康
The company reports a Trailing Twelve Months (TTM) revenue of $17.16B and a net income of $3.65B, while its EBITDA stands at $4.79B. The substantial gap between the $17.16B in revenue and the $3.65B in net income reveals a cost structure where operating expenses and claims payouts consume approximately 78.8% of total revenue, highlighting the capital-intensive nature of the insurance business. Free cash flow for the period reached $5.18B, which indicates strong financial flexibility allowing the firm to service obligations or return capital without relying solely on operating cash conversion. Regarding profitability efficiency, the gross margin is 46.6%, the operating margin is 33.6%, and the profit margin is 21.2%, each figure reflecting the company's ability to control underwriting and administrative costs relative to its premium volume. In terms of leverage, total cash holdings of $7.63B are compared against total debt of $12.59B, resulting in a debt-to-equity ratio of 42.68, which suggests a leveraged balance sheet rather than a conservative one. The current ratio of 1.07 indicates that the company's current assets slightly exceed its current liabilities, pointing to a tight but sufficient short-term liquidity position. Furthermore, the Return on Equity (ROE) is 13.1% and the Return on Assets (ROA) is 2.5%, metrics that collectively reveal management's effectiveness in generating returns on shareholder capital versus the broader asset base utilized to support operations.
估值评估
The valuation metrics show a Trailing P/E ratio of 16.58 and a Forward P/E of 14.59, where the lower forward multiple implies that the market expects earnings to improve in the coming year relative to current performance. The price-to-book ratio is 1.99, which indicates that the market values the company at nearly double its net asset book value, suggesting a premium assigned to its brand, distribution network, or future growth potential. Alternative valuation perspectives include a price-to-sales ratio of 3.45 and an EV/EBITDA of 13.23, which provide context on how much investors are paying for each dollar of sales and earnings before interest, taxes, depreciation, and amortization. Regarding price range volatility, the stock has a 52-week high of $119.32 and a 52-week low of $96.95, meaning the current trading price sits at approximately 50.2% below the 52-week high if calculated relative to the high, though the specific current price is not provided in the facts, the range defines the historical trading band. The beta value is 0.65, which means the stock exhibits price volatility that is significantly lower than the broader market, offering a more stable return profile compared to high-beta equities.
Growth & Income
Recent performance data indicates a revenue growth of -9.9% YoY and an earnings growth of -22.9% YoY, where earnings are shrinking at a much faster rate than revenue, implying potential pressure on underwriting results or expense ratios that has disproportionately impacted the bottom line. As a dividend payer, the company offers a dividend yield of 2.2% with a payout ratio of 34.0%, a level that appears sustainable given the earnings figures, as the payout consumes a moderate portion of the generated profit. The decline in earnings growth relative to revenue suggests that the cost structure or expense environment may be deteriorating faster than premium generation capabilities in the current fiscal cycle. Overall, the company's profile combines a moderate dividend yield with recent contraction in earnings, presenting a scenario where income is maintained but capital appreciation may be challenged by the negative growth trajectory observed in the most recent data.